Sliwa K., Damasceno A., Mayosi BMEpidemiology and etiology of cardiomyopathy in Africa. Circulation . 2005; 112:3577-3583.
2.
Parry EH, Abrahams DGThe natural history of endomyocardial fibrosis. Q J Med. 1965;34:383-408.
3.
Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MKClinical course of endomyocardial fibrosis. Br Heart J. 1989;62:450-454.
4.
Freers J., Masembe V., Schmauz R., Mayanja-Kizza H.Endomyocardial fibrosis syndrome in Uganda. Lancet . 2000;355:1994-1995.
5.
Olsen EGJ.Morphological overview and pathogenic mechanisms in endomyocardial fibrosis associated with eosinophilia. In: Olsen EGJ, Segikochi M, eds. Cardiomyopathy Update 3. Tokyo, Japan: University of Tokyo Press, Tokyo; 1990:1-8.
6.
Andy JJ, Ogunowo PO, Akpan NA, Odigwe CO, Ekanem IA, Esin RAHelminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Acta Trop. 1998;69:127-140.
7.
Rutakingirwa M., Ziegler JL, Newton R., Freers J.Poverty and eosinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda. Trop Med Int Health. 1999; 4:229-235.
8.
Sezi CLEffect of protein deficient cassava diet on Cercopithecus aethiops hearts and its possible role in the aetiology and pathogenesis of endomyocardial fibrosis in man. East Afr Med J. 1996;73(suppl 5):S11-S16.
9.
Hassan WM, Fawzy ME, Al Helaly S., Hegazy H., Malik S.Pitfalls in diagnosis and clinical, echocardiographic, and hemodynamic findings in endomyocardial fibrosis: a 25-year experience. Chest. 2005;128:3985-3992.
Schneider U. , Jenni R., Turina J., Turina M., Hess OMLong-term follow up of patients with endomyocardial fibrosis: effects of surgery. Heart. 1998;79:362-367.